Showing results (101-110 of 288) with videos related to

Sort By:
Pageof 29
The Medical Journal of Australia|January 11, 2024
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort studyLuke S McLean, Annette M Lim, Mathias Bressel, et al.
Journal of Applied Clinical Medical Physics|August 29, 2025
Single- versus multi-model in the deep learning prediction of monitor units per control point for automated treatment planning in prostate cancerMathieu Gaudreault, Lachlan McIntosh, Katrina Woodford, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|July 20, 2025
Effect of arc length on the deep learning prediction of monitor units in lung stereotactic ablative radiation therapy treatmentMathieu Gaudreault, Lachlan McIntosh, Katrina Woodford, et al.
Asia-Pacific Journal of Clinical Oncology|June 8, 2026
Oncology Inpatient Resuscitation Planning and Long-Term "Rapid Response Call" OutcomesDhanashree Tikhe, Petition Nhira, Megan Kepreotis, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 30, 2016
Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab ImmunotherapyFiona Day, Mahesh Kumar, Linda Fenton, et al.
Journal of Clinical Forensic Medicine|February 9, 2006
A retrospective case series of skeletal surveys in children with suspected non-accidental injuryFiona Day, Sarah Clegg, Maeve McPhillips, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2017
Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for CisplatinJune Corry, Mathias Bressel, Tsien Fua, et al.
Head & Neck|December 19, 2015
PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients with recurrent or metastatic squamous cell carcinoma of the head and neckDanny Rischin, David R Spigel, Douglas Adkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study--TROG 96:07Michael Poulsen, Danny Rischin, Euan Walpole, et al.
Journal of Medical Imaging and Radiation Oncology|February 7, 2018
Prospective analysis of the utility of 18-FDG PET in Merkel cell carcinoma of the skin: A Trans Tasman Radiation Oncology Group Study, TROG 09:03Michael Poulsen, David Macfarlane, Michael Veness, et al.
Pageof 29